Jazz Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.About JAZZ
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio.
CEORenée D. Galá
CEORenée D. Galá
Employees2,800
Employees2,800
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2005
Founded2005
Employees2,800
Employees2,800
JAZZ Key Statistics
Market cap7.95B
Market cap7.95B
Price-Earnings ratio-19.20
Price-Earnings ratio-19.20
Dividend yield—
Dividend yield—
Average volume668.39K
Average volume668.39K
High today$131.62
High today$131.62
Low today$128.42
Low today$128.42
Open price$129.65
Open price$129.65
Volume858.30K
Volume858.30K
52 Week high$148.06
52 Week high$148.06
52 Week low$95.49
52 Week low$95.49
JAZZ News
TipRanks 6d
Jazz Pharmaceuticals’ ZW25 Study Update: A Potential Game-Changer in Cancer TreatmentJazz Pharmaceuticals ((JAZZ)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...
Analyst ratings
95%
of 20 ratingsBuy
95%
Hold
5%
Sell
0%
People also own
Based on the portfolios of people who own JAZZ. This list is generated using Robinhood data, and it’s not a recommendation.